Average Co-Inventor Count = 5.43
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada & Co. (11 from 76 patents)
2. Merck Frosst Canada, Inc. (7 from 212 patents)
3. Kaneq Pharma Inc. (4 from 4 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Merck Frosst Company (1 from 2 patents)
6. Merck Canada Inc. (40 patents)
24 patents:
1. 9334295 - Fused aromatic PTP-1B inhibitors
2. 8927526 - Fused aromatic PTP-1B inhibitors
3. 8685999 - Beta carboline sulphonylurea derivatives as EP4 receptor antagonists
4. 8481742 - Fused aromatic PTP-1B inhibitors
5. 8168815 - Fused aromatic PTP-1B inhibitors
6. 7622501 - Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
7. 7618979 - Pyridopyrrolizine and pyridoindolizine derivatives
8. 7199154 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
9. 7163932 - Aryldifluoromethylphosphonic acids for treatment of diabetes
10. 7144913 - Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
11. 6777433 - Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
12. 6583126 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
13. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
14. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
15. 6448429 - Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates